Trudeke G.M. Möller (Capelle aan den Ijssel, Netherlands), Christian Taube (Leiden, Netherlands), Anders Linden (Stockholm, Sweden), Gary P. Anderson (Parkville, Australia)
Macrophage subsets in lung tissue of healthy controls and asthma patients
Barbro Melgert (Groningen, Netherlands), Christina Draijer, Carian Boorsma, Patricia Robbe, Machteld Hylkema, Wim Timens, Maarten Van den Berge, Dirkje Postma, Barbro Melgert
|  |
The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma
Nikolaos Lazarinis (Stockholm, Sweden), Nikolaos Lazarinis, Johan Bood, Craig Wheelock, Sven-Erik Dahlén, Barbro Dahlén
| |
Characteristics of asthma in U-BIOPRED severe and non-severe cohorts with distinct biomarker profiles
Edward Ingenito (Cambridge, United States of America), Edward Ingenito, Jeanette Bigler, Dirk Smith, Anthony Rowe, Fan Chung, Ratko Djukanovic, Ana Sousa, Ian Adcock, Peter Sterk, Ajay Nirula
| |
Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma
Xiujuan YAO (Beijing, China), Xiujuan Yao, Wei Wang, Kewu Huang, Chris J. Corrigan, Yong Chang Sun, Sun Ying, Xiujuan Yao
|  |
The role of antioxidant enzymes in the pathogenesis of asthma and the formation of the features of its clinical course
Ramziddin Kholliev (Samarkand, Uzbekistan), Ramziddin Kholliyev, Musa Khaydarov, Khikmat Turayev, Jamshid Ismailov
| |
Hypersensitivity pneumonitis: Clinical spectrum and outcome
Chirine Moussa (Ezahra, Tunisia), Chirine Moussa, Besma Hamdi, Anissa Berraies, Alaa Akaad, Saberine Louhaichi, Jamel Ammar, Agnes Hamzaoui
| |
Importance of levels production of Il-4 in the pathogenesis and formation of the phenotype of asthma
Gulbahor Fazilova (Samarkand, Uzbekistan), Gulbahor Fazilova
| |
IL5 and IL13 modulate trans-compartmental activation and migration of eosinophils
Sebastian Reuter (Mainz, Germany), Sebastian Reuter, Helen Meyer-Martin, Hendrik Beckert, Roland Buhl
| |
MicroRNA-146a and microRNA-155 expression in induced sputum of allergic asthmatics
Carina Malmhäll (Göteborg, Sweden), Carina Malmhäll, Sahar Alawieh, Jan Lötvall, Madeleine Rådinger
| |
Intranasal GSK2245035 induces prolonged reductions in nasal responsiveness to allergen
Anne Ellis (Kingston, Canada), Anne K. Ellis, Diana Quint, Will Powley, Laurie A. Lee
| |
A randomized, placebo-controlled trial using anti-IgE to treat allergic bronchopulmonary aspergillosis
Astrid Voskamp (Leiden, Netherlands), Astrid Voskamp, Andrew Gillman, Karen Symons, Alessandra Sandrini, Jennifer Rolland, Robyn O’Hehir
| |
Environmental factors in schools determining exercise-induced symptoms in children
Iwona Stelmach (Łódź, Poland), Iwona Stelmach, Lukasz Cichalewski, Wlodzimierz Stelmach, Daniela Podlecka, Joanna Jerzynska
| |
Characterisation of adipose tissue macrophage phenotypes in obese asthma
Hashim Periyalil (Fletcher, Australia), Hashim Periyalil, Lisa Wood, Tim Wright, Costa Karihaloo, Peter Gibson
| |
CCD contributes for cross-reactivity between food allergen and Bermuda and Timothy pollen allergen in Southern China
Wenting Luo (Guangzhou, China), Wenting Luo, Baoqing Sun
| |
Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium
Irene Heijink (Groningen, Netherlands), Irene Heijink, Marnix Jonker, Dirkje Postma, Maarten Van den Berge
| |
Placebo controlled trial of vitamin D supplementation in allergic rhinitis
Balakrishnan Menon (Delhi, India), Balakrishnan Menon, Yusuf Dar, Tinu Garg, Harish Bhatia, Charanjeet Kaur
| |
Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran
Mozhgan Moghtaderi (Shiraz, Islamic Republic of Iran), Mozhgan Moghtaderi, Shirin Farjadian, Zeinab Hosseini
| |
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Claus Kroegel (Jena, Germany), Claus Kroegel, Martin Foerster, Kristin Lerche, Maryam Aalamian-Mattheis, Janett Happe, Anne Moeser, Stephanie Korn
| |
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Eva Martinez Moragon (Valencia, Spain), Eva Martínez Moragón, Fernando Sanchez-Toril Lopez, Miguel Díaz Palacios, Juan José Liñana Santafe, Marta Lleonart Dormuà
| |
TNF-α, IL-6, IL-10 serum activity in patients with obesity-associated arterial hypertension depend on bronchial obstruction presence
Kseniia Sytnyk (Kharkiv, Ukraine), Kseniia Sytnyk, Butov Dmytro
| |